219 related articles for article (PubMed ID: 30580129)
1. The association of pre- and posthospital medication adherence in myocardial infarction patients.
Doll JA; Hellkamp AS; Thomas L; Fonarow GC; Peterson E; Wang TY
Am Heart J; 2019 Feb; 208():74-80. PubMed ID: 30580129
[TBL] [Abstract][Full Text] [Related]
2. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
3. Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
O'Brien EC; McCoy LA; Thomas L; Peterson ED; Wang TY
Am Heart J; 2015 Jul; 170(1):55-61. PubMed ID: 26093864
[TBL] [Abstract][Full Text] [Related]
4. Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.
Wang TY; Kaltenbach LA; Cannon CP; Fonarow GC; Choudhry NK; Henry TD; Cohen DJ; Bhandary D; Khan ND; Anstrom KJ; Peterson ED
JAMA; 2019 Jan; 321(1):44-55. PubMed ID: 30620370
[TBL] [Abstract][Full Text] [Related]
5. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs.
Doll JA; Kaltenbach LA; Anstrom KJ; Cannon CP; Henry TD; Fonarow GC; Choudhry NK; Fonseca E; Bhalla N; Eudicone JM; Peterson ED; Wang TY
J Am Heart Assoc; 2020 Apr; 9(8):e014975. PubMed ID: 32299284
[TBL] [Abstract][Full Text] [Related]
6. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
[TBL] [Abstract][Full Text] [Related]
7. Hospital Variation in Adherence Rates to Secondary Prevention Medications and the Implications on Quality.
Mathews R; Wang W; Kaltenbach LA; Thomas L; Shah RU; Ali M; Peterson ED; Wang TY
Circulation; 2018 May; 137(20):2128-2138. PubMed ID: 29386204
[TBL] [Abstract][Full Text] [Related]
8. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Anstrom KJ; Fonarow GC; Henry TD; Cannon CP; Choudhry NK; Cohen DJ; Atreja N; Bhalla N; Eudicone JM; Wang TY
Circ Cardiovasc Qual Outcomes; 2020 May; 13(5):e006182. PubMed ID: 32393129
[TBL] [Abstract][Full Text] [Related]
9. It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality.
Hickson RP; Robinson JG; Annis IE; Killeya-Jones LA; Fang G
J Am Heart Assoc; 2019 Apr; 8(7):e011378. PubMed ID: 30929542
[TBL] [Abstract][Full Text] [Related]
10. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
11. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
[TBL] [Abstract][Full Text] [Related]
12. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
13. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.
Kronish IM; Ross JS; Zhao H; Muntner P
Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):364-71. PubMed ID: 27220368
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction.
Doll JA; Wang TY; Choudhry NK; Cannon CP; Cohen DJ; Fonarow GC; Henry TD; Bhandary DD; Khan N; Davidson-Ray LD; Anstrom K; Peterson ED
Am Heart J; 2016 Jul; 177():33-41. PubMed ID: 27297847
[TBL] [Abstract][Full Text] [Related]
16. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
[TBL] [Abstract][Full Text] [Related]
17. Early Medication Nonadherence After Acute Myocardial Infarction: Insights into Actionable Opportunities From the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Mathews R; Peterson ED; Honeycutt E; Chin CT; Effron MB; Zettler M; Fonarow GC; Henry TD; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):347-56. PubMed ID: 26038524
[TBL] [Abstract][Full Text] [Related]
18. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
Majd Z; Mohan A; Paranjpe R; Abughosh SM
J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
[No Abstract] [Full Text] [Related]
19. Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction.
Colantonio LD; Deng L; Chen L; Farkouh ME; Monda KL; Harrison DJ; Maya JF; Kilgore ML; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Dec; 32(6):601-610. PubMed ID: 30446883
[TBL] [Abstract][Full Text] [Related]
20. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
